AstraZeneca
AZN
1,230 hedge funds and large institutions have $39.1B invested in AstraZeneca in 2024 Q3 according to their latest regulatory filings, with 117 funds opening new positions, 495 increasing their positions, 397 reducing their positions, and 89 closing their positions.
45% more call options, than puts
Call options by funds: $485M | Put options by funds: $334M
31% more first-time investments, than exits
New positions opened: 117 | Existing positions closed: 89
25% more repeat investments, than reductions
Existing positions increased: 495 | Existing positions reduced: 397
1% more funds holding
Funds holding: 1,212 → 1,230 (+18)
0% more capital invested
Capital invested by funds: $39B → $39.1B (+$46.1M)
0.03% more ownership
Funds ownership: 16.11% → 16.14% (+0.03%)
11% less funds holding in top 10
Funds holding in top 10: 19 → 17 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$808M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
+$200M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$130M |
| 4 |
D.E. Shaw & Co
New York
|
+$126M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$123M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$268M |
| 2 |
Holocene Advisors
New York
|
-$197M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$188M |
| 4 |
Jennison Associates
New York
|
-$166M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$165M |
AZN Hedge Fund Activity: Q3 2024 in Review
1,230 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q3 2024, worth a combined $39.1B — up 0.12% from $39B a quarter earlier.
Buyers outnumbered sellers: 117 funds opened new AZN positions and 89 closed out — a net gain of 28 holders — while 495 added to existing stakes and 397 trimmed.
The largest buyer was Bank of America, adding an estimated $808M. The largest seller was Wellington Management Group, cutting an estimated $268M.
- 1,230 institutional investors held AstraZeneca (AZN) as of Q3 2024, up from 1,212 in Q2 2024.
- Funds reported $39.1B of AstraZeneca stock for Q3 2024, up 0.12% quarter-over-quarter.
- 117 funds opened new AstraZeneca positions in Q3 2024 and 89 closed out, a net change of +28 holders.
- The largest AstraZeneca buyer in Q3 2024 was Bank of America, an estimated $808M added.
- The largest AstraZeneca seller in Q3 2024 was Wellington Management Group, an estimated $268M sold.
Based on aggregated 13F filings for Q3 2024.